Literature DB >> 21274970

Support vector machine multiparametric MRI identification of pseudoprogression from tumor recurrence in patients with resected glioblastoma.

Xintao Hu1, Kelvin K Wong, Geoffrey S Young, Lei Guo, Stephen T Wong.   

Abstract

PURPOSE: To automatically differentiate radiation necrosis from recurrent tumor at high spatial resolution using multiparametric MRI features.
MATERIALS AND METHODS: MRI data retrieved from 31 patients (15 recurrent tumor and 16 radiation necrosis) who underwent chemoradiation therapy after surgical resection included post-gadolinium T1, T2, fluid-attenuated inversion recovery, proton density, apparent diffusion coefficient (ADC), and perfusion-weighted imaging (PWI) -derived relative cerebral blood volume (rCBV), relative cerebral blood flow (rCBF), and mean transit time maps. After alignment to post contrast T1WI, an eight-dimensional feature vector was constructed. An one-class-support vector machine classifier was trained using a radiation necrosis training set. Classifier parameters were optimized based on the area under receiver operating characteristic (ROC) curve. The classifier was then tested on the full dataset.
RESULTS: The sensitivity and specificity of optimized classifier for pseudoprogression was 89.91% and 93.72%, respectively. The area under ROC curve was 0.9439. The distribution of voxels classified as radiation necrosis was supported by the clinical interpretation of follow-up scans for both nonprogressing and progressing test cases. The ADC map derived from diffusion-weighted imaging and rCBV, rCBF derived from PWI were found to make a greater contribution to the discrimination than the conventional images.
CONCLUSION: Machine learning using multiparametric MRI features may be a promising approach to identify the distribution of radiation necrosis tissue in resected glioblastoma multiforme patients undergoing chemoradiation.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21274970      PMCID: PMC3273302          DOI: 10.1002/jmri.22432

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  33 in total

Review 1.  Radiation injury to the nervous system.

Authors:  P New
Journal:  Curr Opin Neurol       Date:  2001-12       Impact factor: 5.710

2.  Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis.

Authors:  Mark E Mullins; Glenn D Barest; Pamela W Schaefer; Fred H Hochberg; R Gilberto Gonzalez; Michael H Lev
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

3.  Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study.

Authors:  Ivan M Dequesada; Ronald G Quisling; Anthony Yachnis; William A Friedman
Journal:  Neurosurgery       Date:  2008-11       Impact factor: 4.654

Review 4.  The fallacy of the localized supratentorial malignant glioma.

Authors:  E C Halperin; P C Burger; D E Bullard
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-08       Impact factor: 7.038

5.  Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence.

Authors:  Chiaki Asao; Yukunori Korogi; Mika Kitajima; Toshinori Hirai; Yuji Baba; Keishi Makino; Masato Kochi; Shoji Morishita; Yasuyuki Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

6.  Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells.

Authors:  V Jung; B F Romeike; W Henn; W Feiden; J R Moringlane; K D Zang; S Urbschat
Journal:  J Neuropathol Exp Neurol       Date:  1999-09       Impact factor: 3.685

7.  Inverse correlation between choline magnetic resonance spectroscopy signal intensity and the apparent diffusion coefficient in human glioma.

Authors:  R K Gupta; U Sinha; T F Cloughesy; J R Alger
Journal:  Magn Reson Med       Date:  1999-01       Impact factor: 4.668

8.  Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study.

Authors:  S W Lee; B A Fraass; L H Marsh; K Herbort; S S Gebarski; M K Martel; E H Radany; A S Lichter; H M Sandler
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-01-01       Impact factor: 7.038

9.  Multiparametric tissue characterization of brain neoplasms and their recurrence using pattern classification of MR images.

Authors:  Ragini Verma; Evangelia I Zacharaki; Yangming Ou; Hongmin Cai; Sanjeev Chawla; Seung-Koo Lee; Elias R Melhem; Ronald Wolf; Christos Davatzikos
Journal:  Acad Radiol       Date:  2008-08       Impact factor: 3.173

Review 10.  Advanced MRI of adult brain tumors.

Authors:  Geoffrey S Young
Journal:  Neurol Clin       Date:  2007-11       Impact factor: 3.806

View more
  60 in total

Review 1.  [Multiparametric imaging with simultaneous MRI/PET: Methodological aspects and possible clinical applications].

Authors:  S Gatidis; H Schmidt; C D Claussen; N F Schwenzer
Journal:  Z Rheumatol       Date:  2015-12       Impact factor: 1.372

2.  Prediction of pseudoprogression in patients with glioblastomas using the initial and final area under the curves ratio derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging.

Authors:  C H Suh; H S Kim; Y J Choi; N Kim; S J Kim
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-04       Impact factor: 3.825

Review 3.  [Multiparametric imaging with simultaneous MR/PET. Methodological aspects and possible clinical applications].

Authors:  S Gatidis; H Schmidt; C D Claussen; N F Schwenzer
Journal:  Radiologe       Date:  2013-08       Impact factor: 0.635

4.  Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach.

Authors:  Alfonso Di Costanzo; Tommaso Scarabino; Francesca Trojsi; Teresa Popolizio; Simona Bonavita; Mario de Cristofaro; Renata Conforti; Adriana Cristofano; Claudio Colonnese; Ugo Salvolini; Gioacchino Tedeschi
Journal:  Radiol Med       Date:  2014-01-10       Impact factor: 3.469

5.  Pseudo progression identification of glioblastoma with dictionary learning.

Authors:  Jian Zhang; Hengyong Yu; Xiaohua Qian; Keqin Liu; Hua Tan; Tielin Yang; Maode Wang; King Chuen Li; Michael D Chan; Waldemar Debinski; Anna Paulsson; Ge Wang; Xiaobo Zhou
Journal:  Comput Biol Med       Date:  2016-04-01       Impact factor: 4.589

Review 6.  Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies.

Authors:  Nishant Verma; Matthew C Cowperthwaite; Mark G Burnett; Mia K Markey
Journal:  Neuro Oncol       Date:  2013-01-16       Impact factor: 12.300

7.  Predicting a multi-parametric probability map of active tumor extent using random forests.

Authors:  Fred W Prior; Sarah J Fouke; Tammie Benzinger; Alicia Boyd; Michael Chicoine; Sharath Cholleti; Matthew Kelsey; Bart Keogh; Lauren Kim; Mikhail Milchenko; David G Politte; Stephen Tyree; Kilian Weinberger; Daniel Marcus
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2013

8.  Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question.

Authors:  Morad Nasseri; Seymur Gahramanov; Joao Prola Netto; Rongwei Fu; Leslie L Muldoon; Csanad Varallyay; Bronwyn E Hamilton; Edward A Neuwelt
Journal:  Neuro Oncol       Date:  2014-02-11       Impact factor: 12.300

Review 9.  Post-treatment imaging changes in primary brain tumors.

Authors:  Barbara J O'Brien; Rivka R Colen
Journal:  Curr Oncol Rep       Date:  2014       Impact factor: 5.075

10.  Assessment of disease severity in late infantile neuronal ceroid lipofuscinosis using multiparametric MR imaging.

Authors:  J P Dyke; D Sondhi; H U Voss; D C Shungu; X Mao; K Yohay; S Worgall; N R Hackett; C Hollmann; M E Yeotsas; A L Jeong; B Van de Graaf; I Cao; S M Kaminsky; L A Heier; K D Rudser; M M Souweidane; M G Kaplitt; B Kosofsky; R G Crystal; D Ballon
Journal:  AJNR Am J Neuroradiol       Date:  2012-10-04       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.